Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs
Forbes
Mon, 04/12/21 - 11:04 pm
legislation
CBO
drug pricing
R&D
Life sciences pumping more cash than ever into R&D, but drug pricing limits could stymie that tide: report
Fierce Pharma
Fri, 04/9/21 - 10:36 am
drug pricing
R&D
With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers
MedCity News
Wed, 04/7/21 - 10:38 am
Volastra Therapeutics
cancer metastasis
cancer
R&D
Microsoft
funding
Biden puts R&D investment at heart of $2T spending plan
Fierce Biotech
Thu, 04/1/21 - 10:57 am
Joe Biden
R&D
pandemic
drug development
Omega Therapeutics adds $126M to move “programmable” drugs closer to the clinic
MedCity News
Tue, 03/30/21 - 11:55 am
Omega Therapeutics
R&D
programmable drugs
cancer
As Alkermes shines light on early cancer, neuro assets, biotech searches for collabs, strategic ops
Fierce Biotech
Fri, 03/26/21 - 10:47 am
Alkermes
R&D
cancer
immuno-oncology
COVID-19 drives Boehringer’s R&D spend to record level in 2020
Pharmaforum
Thu, 03/25/21 - 11:49 am
Boehringer Ingelheim
R&D
COVID-19
LEO Pharma’s new R&D lead on driving agility in drug development
Pharmaforum
Wed, 03/24/21 - 11:22 pm
LEO Pharma
R&D
Jörg Möller
XyloCor bags $23M to expand heart disease gene therapy R&D
Fierce Biotech
Mon, 03/22/21 - 10:46 am
XyloCor Therapeutics
gene therapy
VEGF
heart disease
clinical trials
R&D
José Baselga, acclaimed drug hunter, physician and AstraZeneca's pioneering cancer R&D chief, has died
Endpoints
Sun, 03/21/21 - 11:53 pm
Jose Baselga
AstraZeneca
R&D
oncology
Gilead, Novo Nordisk push NASH cocktail deeper into the clinic
Fierce Biotech
Thu, 03/18/21 - 10:54 am
Gilead Sciences
Novo Nordisk
NASH
R&D
How Covid-19 is changing rare diseases research
MedCity News
Wed, 03/10/21 - 10:29 am
COVID-19
Rare Diseases
R&D
Lilly, Biolojic to develop antibody therapies for diabetes treatment
Pharmaceutical Business Review
Tue, 03/9/21 - 10:33 am
Eli Lilly
Biolojic Design
diabetes
R&D
These Four Policy Changes Could Help Us Get Vaccines For The Next Pandemic Even Faster
Forbes
Wed, 03/3/21 - 12:04 am
vaccines
FDA
pandemic
R&D
clinical trials
Artiva, fresh from Merck pact, raises $120M for NK therapy R&D
Fierce Biotech
Mon, 03/1/21 - 10:39 am
Artiva
natural killer cell therapy
Merck
R&D
Genentech teams with academics for 10-year neuroscience R&D push
Fierce Biotech
Sun, 02/28/21 - 10:12 pm
Genentech
R&D
Neuroscience
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
Fri, 02/19/21 - 10:33 am
pharma industry
R&D
pandemic
earnings
COVID-19
Biogen
GW Pharma
Jazz Pharmaceuticals
GSK
Merck KGaA
Indegene gains $200m backing for expansion plans
Pharmaforum
Mon, 02/8/21 - 10:29 am
Indegene
expansion
R&D
GSK culls cancer, rare disease meds amid Q4 clear-out
Fierce Biotech
Wed, 02/3/21 - 10:51 am
GSK
earnings
R&D
drug development
Lilly cancer R&D chief Bilenker quits, handing reins to deputy
Fierce Biotech
Tue, 02/2/21 - 11:09 pm
Eli Lilly
R&D
Josh Bilenker
Loxo Oncology
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »